News Archive - 2016

News Archive - 2016

Biogen joins pioneering target validation collaboration CTTV

cttvbiogensmaller.jpg

Biogen joins pioneering target validation collaboration CTTV

The Centre for Therapeutic Target Validation welcomes new member Biogen, expanding its efforts to accelerate drug discovery research

Biogen has joined the Centre for Therapeutic Target Validation (CTTV), the pioneering public-private collaboration to improve the success rate for discovering new medicines. Originally formed by GSK, the Wellcome Trust Sanger Institute and the European Bioinformatics Institute (EMBL-EBI), the CTTV fosters interactions between academic and industry members to select and validate novel targets in drug development.

Ancient genomes reveal that the English are one third Anglo-Saxon

skeletonhome.jpg

Ancient genomes reveal that the English are one third Anglo-Saxon

DNA from ancient British skeletons reveals immigrant history

For the first time, researchers have been able to directly estimate the Anglo-Saxon ancestry of the British population from ancient skeletons, showing how Anglo-Saxon immigrants mixed with the native population

Parallel single-cell profiling now possible

Image.jpg

Parallel single-cell profiling now possible

New protocol allows links between DNA methylation and gene expression to be studied in the same cells

A new single-cell genomics method to study links between DNA modifications (methylation) and the activity of a gene has been developed. This is the first method that allows scientists to study the epigenome and transcriptome of a single cell in parallel, helping researchers pinpoint the relationship between changes in DNA methylation and gene expression.

Pages